University of Wollongong
Browse

The cost of asthma medicines

Download (197.31 kB)
journal contribution
posted on 2024-11-15, 01:46 authored by Helen K Reddel, Kirsty Lembke, Nicholas Zwar
Most adults and adolescents with asthma require a preventer inhaler. In Australia these patients are often prescribed a combination inhaler containing a corticosteroid and a long-acting beta 2 agonist. These combination inhalers increase the cost of treatment for patients and for government and may not provide extra benefit. Many patients can control their asthma using an inhaled corticosteroid alone for prevention of symptoms and flare-ups. Most of the benefits of inhaled corticosteroids are obtained at low doses. To achieve these benefits it is important to check that the patient is using their inhaler correctly and regularly. Shared decision making includes discussing the options for treatment. Offering a more affordable preventer regimen could aid adherence and lead to improved outcomes.

History

Citation

Reddel, H. K., Lembke, K. & Zwar, N. J. (2018). The cost of asthma medicines. Australian Prescriber, 41 (2), 34-36.

Journal title

Australian Prescriber

Volume

41

Issue

2

Pagination

34-36

Language

English

RIS ID

127522

Usage metrics

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC